Abbreviations ALS: Amyotropic lateral sclerosis AMPA: -Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid BBR: Berberine ChAT: Choline acetyltransferase CK: Creatinkinase CNS: Central nervous system CSA: Chinese scalp acupuncture DATS: Diallyl trisulfide DNA: Deoxy ribonucleic acid EGCG: Epigallocatechin gallate EMG: Electromyography studies FDA: Food and drug administration FVC: Forced vital capacity HupA: Huperzine A IBM: Inclusion body myositis, S Lf: Lactoferrin LMN: Lower motor neurons LPS: Lipopolysaccharide MEP: Motor evoked potentials MN: Spinal motoneuron, MND: Motor Neuron Disease MPP: 1-Methyl-4-phenylpyridinium MRI: Magnetic resonance imaging MSC: Mesenchymal stromal cells NAD: Nicotinamide adenine dinucleotide ND: Neurodegenerative disease NGF: Nerve growth factor NLRP3: NOD-like receptor pyrin domain-containing-3 NMDA: N -Methyl-D-aspartate NR: Nicotinamide riboside PM: Polymyositis PT: Pterostilbene RBP: RNA binding protein ROS: Reactive oxygen species SOD: Superoxide dismutase TMC: N -Trimethylated chitosan UMN: Upper motor neurons US: United States WFA: Withaferin A References Ahmed T, Gilani AU, Abdollahi M, Daglia M, Nabavi SF, Nabavi SM (2015) Berberine and neurodegeneration: a review of literature
Clinical isolates were obtained under an IRB exemption from a pre-existing collection
Abstract In the tumor microenvironment, glutamine has a profound impact not only on the growth, metabolism, metastasis, and invasion of tumor cells but also on the survival and function of immune cells and the behavior of nonimmune cells
By analyzing how drugs affect cellular and tissue-level processes, researchers can elucidate mechanisms of action and refine strategies for drug design and screening
